Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study

Cristina Masini; M.G. Vitale; M. Maruzzo; G. Procopio; U. de Giorgi; S. Buti; S. Rossetti; R. Iacovelli; F. Atzori; L. Cosmai; F. Vignani; G. Prati; S. Scagliarini; A. Guida; A. Berselli; C. Pinto

doi:10.1016/j.clgc.2018.10.001

Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study

Cristina Masini, M.G. Vitale, M. Maruzzo, G. Procopio, U. de Giorgi, S. Buti, S. Rossetti, R. Iacovelli, F. Atzori, L. Cosmai, F. Vignani, G. Prati, S. Scagliarini, A. Guida, A. Berselli, C. Pinto

Research output: Contribution to journal › Article › peer-review

Original language	Italian
Pages (from-to)	e150-e155
Journal	Clinical Genitourinary Cancer
Volume	17
Issue number	1
DOIs	https://doi.org/10.1016/j.clgc.2018.10.001
Publication status	Published - 2019

Access to Document

10.1016/j.clgc.2018.10.001

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055889575&doi=10.1016%2fj.clgc.2018.10.001&partnerID=40&md5=a75abf223c191d0437fcb1ee204505ce

Cite this

Masini, C., Vitale, M. G., Maruzzo, M., Procopio, G., de Giorgi, U., Buti, S., Rossetti, S., Iacovelli, R., Atzori, F., Cosmai, L., Vignani, F., Prati, G., Scagliarini, S., Guida, A., Berselli, A., & Pinto, C. (2019). Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study. Clinical Genitourinary Cancer, 17(1), e150-e155. https://doi.org/10.1016/j.clgc.2018.10.001

Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study. / Masini, Cristina; Vitale, M.G.; Maruzzo, M.; Procopio, G.; de Giorgi, U.; Buti, S.; Rossetti, S.; Iacovelli, R.; Atzori, F.; Cosmai, L.; Vignani, F.; Prati, G.; Scagliarini, S.; Guida, A.; Berselli, A.; Pinto, C.

In: Clinical Genitourinary Cancer, Vol. 17, No. 1, 2019, p. e150-e155.

Research output: Contribution to journal › Article › peer-review

Masini, C, Vitale, MG , Maruzzo, M , Procopio, G , de Giorgi, U, Buti, S, Rossetti, S, Iacovelli, R, Atzori, F, Cosmai, L, Vignani, F, Prati, G, Scagliarini, S, Guida, A, Berselli, A & Pinto, C 2019, 'Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study', Clinical Genitourinary Cancer, vol. 17, no. 1, pp. e150-e155. https://doi.org/10.1016/j.clgc.2018.10.001

Masini, Cristina ; Vitale, M.G. ; Maruzzo, M. ; Procopio, G. ; de Giorgi, U. ; Buti, S. ; Rossetti, S. ; Iacovelli, R. ; Atzori, F. ; Cosmai, L. ; Vignani, F. ; Prati, G. ; Scagliarini, S. ; Guida, A. ; Berselli, A. ; Pinto, C. / Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study. In: Clinical Genitourinary Cancer. 2019 ; Vol. 17, No. 1. pp. e150-e155.

@article{f92788e74c674a7990203677149152e1,

title = "Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study",

author = "Cristina Masini and M.G. Vitale and M. Maruzzo and G. Procopio and {de Giorgi}, U. and S. Buti and S. Rossetti and R. Iacovelli and F. Atzori and L. Cosmai and F. Vignani and G. Prati and S. Scagliarini and A. Guida and A. Berselli and C. Pinto",

note = "Cited By :2 Export Date: 25 February 2020",

year = "2019",

doi = "10.1016/j.clgc.2018.10.001",

language = "Italian",

volume = "17",

pages = "e150--e155",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study

AU - Masini, Cristina

AU - Vitale, M.G.

AU - Maruzzo, M.

AU - Procopio, G.

AU - de Giorgi, U.

AU - Buti, S.

AU - Rossetti, S.

AU - Iacovelli, R.

AU - Atzori, F.

AU - Cosmai, L.

AU - Vignani, F.

AU - Prati, G.

AU - Scagliarini, S.

AU - Guida, A.

AU - Berselli, A.

AU - Pinto, C.

N1 - Cited By :2 Export Date: 25 February 2020

PY - 2019

Y1 - 2019

U2 - 10.1016/j.clgc.2018.10.001

DO - 10.1016/j.clgc.2018.10.001

M3 - Articolo

VL - 17

SP - e150-e155

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

SN - 1558-7673

IS - 1

ER -